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Bone has a mechanical function. A material to replace it should 
therefore be able to take over this function. Screws and plates 
do this, so literally speaking steel is really a bone replacement 
material. But this term is usually reserved for other materials: 
various calcium phosphates, calcium sulphate (actually plaster 
of Paris), bioglass, polymers, titanium granules, chitosan etc. 
It is thought that a perfect bone replacement material should 
be  biocompatible  and  have  good  mechanical  strength,  but 
should also (for some reason) be replaced by host bone over 
time. In addition, it should preferably be injectable. 
Replacement of the implanted material by host bone is a 
complex procedure. It requires that the material should be 
porous and have an “osteoconductive” surface, but it must 
also have the ability to dissolve or be resorbed by osteoclasts. 
Dissolution is virtually impossible, however, once the material 
has fulfilled its function and become covered and sealed by 
host bone. If it is dissolved before being covered, it cannot, by 
definition, be osteoconductive.
When, then, does bone need to be replaced? By far the most 
common indication is bone loss due to prosthetic loosening. 
Here, we mainly use compacted allogeneic bone grafts. This 
material contains immunogenic tissue components, remnants 
of  cartilage,  fibrous  tissue,  and  bone  marrow,  all  necrotic. 
Its osteoconductive or osteoinductive properties are weak or 
absent. Still, it works marvellously well! It takes up load in 
a suitably elastic way, is quickly infiltrated by fibrous tissue, 
and slowly becomes replaced by host bone (which might not 
be necessary for its function). Considering the composition of 
allogeneic bone grafts, it is tempting to think that other mate-
rials with similar mechanics might be even better. But who 
dares to change a winning team?
Intercalary bone defects are too large to be treated with bone 
replacement materials: osteoconduction is a matter of milli-
meters, not centimeters. So, excluding prosthesis revision and 
large defects: which indications remain for these materials? 
– Bone cysts! Bone cysts have aroused (false) hopes for many 
biomaterial researchers and companies who have a new mate-
rial, searching for an indication. In this issue of Acta Orthopae-
dica, Hirn et al. (pp 4-8) and Yanagawa et al.  (pp 9-13) dem-
onstrate that benign bone cysts need no other treatment than 
curettage. Moreover, if fracture still occurs, this is during the 
first postoperative period, before any bone replacement mate-
rial would have been incorporated and added to bone strength. 
This is what many orthopedic surgeons already believe, based 
on experience. It is good to have evidence now. Much unnec-
essary grafting can now be avoided. But will it?Acta Orthopaedica 2009; 80 (1): 2–3  3
It is likely that the radiographic appearance of voids in the 
bone  steer  the  thoughts  of  action-inclined  observers,  who 
think that an abnormality in itself is a call for correction. This 
is really fear of emptiness (horror vacui), transformed into a 
surgical indication. (Actually, horror vacui is not a psycho-
logical term, but belongs to Aristotelean physics). The same 
psychology probably lies behind the idea that bone replace-
ment materials should be resorbable: when the void is filled 
with a material, radiographs still look abnormal. We forget that 
patients don’t care about how their radiographs appear—but 
about their interpretation, for which we are responsible. Let’s 
hope that the papers by Hirn et al. and Yanagawa et al. get all 
the attention they deserve. As Göran Bauer, previous Editor in 
Chief of Acta Orthopaedica, often said: “Retreat from over-
treatment”!
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